We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNPSN.L Regulatory News (NPSN)

  • There is currently no data for NPSN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CASH VALUE FRACTIONAL ENTITLEMENTS NASPERS "N" ORD

12 Sep 2019 09:30

RNS Number : 1155M
Naspers Limited
12 September 2019
 

NASPERS LIMITED

(Incorporated in the Republic of South Africa)

(Registration number 1925/001431/06)

JSE share code: NPN ISIN: ZAE000015889

LSE ADS code: NPSN ISIN: US 6315121003

 

("Naspers" or the "Company")

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS AND REGULATIONS OF SUCH JURISDICTION OR REQUIRE THE COMPANY OR PROSUS TO TAKE ANY FURTHER ACTION.

CASH VALUE OF FRACTIONAL ENTITLEMENTS TO NASPERS "N" ORDINARY SHARES PURSUANT TO THE NASPERS N SHARE CAPITALISATION ISSUE

Shareholders are referred to the circular issued by the Company on Friday, 19 July 2019 in relation to, amongst other things, the Capitalisation Issue (Circular). Unless otherwise indicated, capitalised words and terms contained in this announcement shall bear the same meanings ascribed thereto in the Circular.

As set out in the Circular, only whole numbers of Naspers N Ordinary Shares and Naspers M Ordinary Shares will be issued in terms of the Capitalisation Issue and where fractional entitlements to Naspers N Ordinary Shares arise in terms of the Capitalisation Issue, such fractions will be rounded down to the nearest whole number with any remaining fractional entitlements being sold on behalf of such Naspers N Shareholders with the proceeds payable in cash. The cash amount for such fractional entitlements will be determined in accordance with the JSE Listings Requirements and paid to the relevant Naspers N Shareholder in its brokerage account or to a nominee account to be held on behalf and for the benefit of the relevant Naspers N Shareholder as envisaged in the Circular and in accordance with the JSE Listings Requirements.

 

In accordance with the JSE Listings Requirements, this amount has been determined with reference to the volume weighted average price in Rand of a Naspers N Ordinary Share traded on the Johannesburg Stock Exchange on Wednesday, 11 September 2019, ZAR 2,426.10 (being the first day on which Naspers N Ordinary Shares trade 'ex´ the entitlement to participate in the Capitalisation Issue), reduced by 10% ("Cash Proceeds"). On this basis, Shareholders are advised that the Cash Proceeds due to Shareholders in respect of any fractional entitlements is ZAR 2,183.49 (ZAR 2,426.10 x 0.9) per Naspers N Ordinary Share.

 

Cape Town

12 September 2019

 

JSE Sponsor to Naspers

Investec Bank Limited

South African Legal Adviser (Lead)

Webber Wentzel

South African Legal Adviser

Glyn Marais Inc.

Dutch and US Legal Adviser

Allen & Overy LLP

Dutch and US Legal Adviser to Joint Financial Advisers

Linklaters LLP

Joint Financial Advisers

Other Financial Advisers

Goldman Sachs International

Banca IMI S.p.A.

J.P. Morgan Securities plc

Bank of America Merrill Lynch International DAC, Amsterdam Branch

Morgan Stanley & Co. International plc

Barclays Bank PLC

BNP Paribas

Citigroup Global Markets Limited

Deutsche Bank AG, London Branch

ICBC Standard Bank plc

ING Bank N.V.

Naspers ADS Depositary

The Bank of New York Mellon

 

DISCLAIMER

Under the Capital Restructure, Naspers shareholders whose addresses are shown in the securities register of Naspers on the Record Date as being in Australia, Bermuda, Canada, Cayman Islands, the European Economic Area, Japan, Jersey, Panama, the People's Republic of China, South Korea, Switzerland and the United States (or any other jurisdiction in which Naspers reasonably believes that it is not prohibited or unduly onerous or impractical for Shares or Naspers Shares to be issued or delivered to Naspers shareholders) will receive Shares or Naspers Shares, as the case may be, in accordance with terms and conditions of the Naspers Circular.

Naspers N Shareholders must consider the Prospectus and Naspers Circular in full as action is required from them and they should seek advice from their independent advisers in relation to the implications of the Transaction and, in particular, the Election. In addition, Naspers N Shareholders are reminded that the Naspers Circular requires them to take certain actions and provide certain information, including, for example, details of the Euronext Amsterdam Brokerage Account if such shareholder is a non-resident of the Common Monetary Area for exchange control purposes and intends to participate in the Naspers M Share Capitalisation Issue and receive Prosus N Ordinary Shares.

Prospective investors are expressly advised that an investment in Prosus N Ordinary Shares entails certain risks and that they should therefore carefully read and review the entire Prospectus. Prospective investors should not just rely on key information or information summarised within this announcement, the Prospectus or the Abridged Pre-listing Statement. Prospective investors should, in particular, read the section of the Prospectus entitled "Risk Factors" when considering an investment in the Prosus N Ordinary Shares. A prospective investor should not invest in Prosus N Ordinary Shares unless it has the expertise (either alone or with a financial adviser) to evaluate how the Prosus N Ordinary Shares will perform under changing conditions, the resulting effects on the value of the Prosus N Ordinary Shares and the impact this investment will have on the prospective investor's overall investment portfolio. Prospective investors should also consult their own tax advisers as to the tax consequences of the purchase, ownership and disposal of the Prosus N Ordinary Shares.

The content of this announcement, the Prospectus and the Abridged Pre-listing Statement should not be construed as business, legal or tax advice. It is not intended to provide the basis of any credit or other evaluation and should not be considered as a recommendation by any of the Company (or its directors), Prosus (or its Directors) or any of the Financial Advisers, the Euronext Listing and Paying Agent, the JSE Sponsor or any of their respective representatives that any recipient of this announcement, the Prospectus and/or the Abridged Pre-listing Statement should acquire any Prosus N Ordinary Shares. None of the Company, Prosus or any of the Financial Advisers, the Euronext Listing and Paying Agent or the JSE Sponsor, or any of their respective representatives, is making any representation to any prospective investor regarding the legality of an investment in the Prosus N Ordinary Shares by such prospective investor under the laws and regulations applicable to such prospective investor. Prospective investors should consult their own professional adviser before making any investment decision with regard to the Prosus N Ordinary Shares, among other things, to consider such investment decision in light of his or her personal circumstances and in order to determine whether or not such prospective investor is eligible to purchase Prosus N Ordinary Shares. In making an investment decision, prospective investors must rely on their own analysis, enquiry and examination of the Prosus Group and the Prosus N Ordinary Shares, including the merits and risks involved.

The release, publication or distribution of this announcement in jurisdictions other than South Africa may be restricted by law and therefore persons into whose possession this announcement comes, should inform themselves about, and observe, any applicable restrictions or requirements. Any failure to comply with such restrictions may constitute a violation of the securities laws of any such jurisdiction. To the fullest extent permitted by applicable law, Naspers disclaims any responsibility or liability for the violation of such requirements by any person. Notices for prospective investors located in, or resident of, certain jurisdictions are set out in the Prospectus. The Prosus N Ordinary Shares have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended, (the U.S. Securities Act) or the securities laws of any state of the United States.

This announcement does not constitute an offer or form part of any offer or invitation to purchase, subscribe for, sell or issue, or a solicitation of any offer to purchase, subscribe for, sell or issue, any securities including Shares (whether pursuant to this announcement or otherwise) in any jurisdiction, including an offer to the public or section of the public in any jurisdiction.

This announcement, the Prospectus and the Abridged Pre-listing Statement include forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Naspers Group's, and the Prosus Group's, control and all of which are based on the Naspers Group's, and the Prosus Group's, current beliefs and expectations about future events. Forward-looking statements are sometimes identified by the use of forward-looking terminology such as "aim", "annualised", "anticipate", "assume", "believe", "continue", "could", "estimate", "expect", "goal", "hope", "intend", "may", "objective", "plan", "position", "potential", "predict", "project", "risk", "seek", "should", "target", "will" or "would" or the highlights or the negatives thereof, other variations thereon or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this announcement, the Prospectus and the Abridged Pre-listing Statement, and include statements that reflect the Company's and/or Prosus's intentions, beliefs or current expectations and projections about the Prosus Group's future results of operations, financial condition, liquidity, performance, prospects, anticipated growth, strategies and opportunities and the markets in which the Naspers Group and/or the Prosus Group operates. In particular, the statements under the headings "Summary", "Risk Factors", "Dividends and Dividend Policy", "Business" and "Operating and Financial Review" in the Prospectus regarding the Prosus Group's strategy, targets, expectations, objectives, future plans and other future events or prospects are forward-looking statements. These forward-looking statements and other statements contained in this announcement, the Prospectus and the Abridged Pre-listing Statement regarding matters that are not historical facts involve predictions. No assurance can be given that such future results will be achieved; actual events or results may differ materially as a result of risks and uncertainties facing the Naspers Group and/or the Prosus Group. Such risks and uncertainties could cause actual results to vary materially from the future results indicated, expressed or implied in such forward-looking statements. Forward-looking statements in this announcement, the Prospectus and the Abridged Pre-listing Statement speak only as of the date of this announcement, the Prospectus and the Abridged Pre-listing Statement. Except as required by applicable laws and regulations, the Naspers Group expressly disclaims any obligation or undertaking to update or revise the forward-looking statements contained in this announcement to reflect any change in its expectations or any change in events, conditions or circumstances on which such statements are based.

Each Financial Adviser, the Euronext Listing and Paying Agent and the JSE Sponsor is acting exclusively for Naspers and/or Prosus and no one else in connection with the Transaction. None of them will regard any other person (whether or not a recipient of this announcement, the Prospectus and/or the Abridged Pre-listing Statement) as their respective client in relation to the Transaction and will not be responsible to anyone other than the Company and/or Prosus for providing the protections afforded to their respective clients or for giving advice in relation to, respectively, the Transaction or any transaction or arrangement referred to herein.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCVLLBFKKFLBBE
Date   Source Headline
13th Jan 20229:30 amRNSIssue of Debt
11th Jan 20223:15 pmRNSTransaction in Own Shares
7th Jan 20227:00 amRNSDirector/PDMR Shareholding
4th Jan 20223:15 pmRNSTransaction in Own Shares
29th Dec 20217:00 amRNSTransaction in Own Shares
21st Dec 20213:15 pmRNSTransaction in Own Shares
20th Dec 20217:00 amRNSDirectorate Change
20th Dec 20217:00 amRNSDirectorate Change
14th Dec 20213:15 pmRNSTransaction in Own Shares
13th Dec 20213:15 pmRNSNotice of Intention to Delist ADSs from the LSE
7th Dec 20213:15 pmRNSTransaction in Own Shares
30th Nov 20213:15 pmRNSTransaction in Own Shares
25th Nov 20213:30 pmRNSTreasury Stock
23rd Nov 20213:15 pmRNSTransaction in Own Shares
22nd Nov 20217:00 amRNSHalf-year Report
22nd Nov 20217:00 amRNSHalf-year Report
16th Nov 20213:15 pmRNSTransaction in Own Shares
16th Nov 20217:00 amRNSTrading Statement
16th Nov 20217:00 amRNSTrading Statement
9th Nov 20213:15 pmRNSTransaction in Own Shares
2nd Nov 20213:15 pmRNSTransaction in Own Shares
26th Oct 20214:15 pmRNSTransaction in Own Shares
22nd Oct 20211:30 pmRNSClarificatory statement re dividend
21st Oct 20217:50 amRNSClarificatory statement re dividend
19th Oct 20214:15 pmRNSTransaction in Own Shares
12th Oct 20214:15 pmRNSTransaction in Own Shares
5th Oct 20214:15 pmRNSTransaction in Own Shares
4th Oct 20214:50 pmRNSStatement re Delivery Hero transaction
4th Oct 20214:50 pmRNSStatement re Delivery Hero transaction
1st Oct 20217:45 amRNSDirector/PDMR Shareholding
28th Sep 20214:15 pmRNSTransaction in Own Shares
21st Sep 20214:15 pmRNSTransaction in Own Shares
14th Sep 20214:30 pmRNSTransaction in Own Shares
7th Sep 20214:50 pmRNSTransaction in Own Shares
31st Aug 20214:50 pmRNSTransaction in Own Shares
31st Aug 20214:30 pmRNSDirector/PDMR Shareholding
31st Aug 20219:15 amRNSProsus increases stake in Delivery Hero
31st Aug 20219:15 amRNSProsus increases stake in Delivery Hero
31st Aug 20217:00 amRNSacquisition of 100% OF THE equity IN BillDesk
31st Aug 20217:00 amRNSacquisition of 100% OF THE equity IN BillDesk
26th Aug 20214:30 pmRNSDirectorate Change
26th Aug 20214:30 pmRNSDirectorate Change
25th Aug 20214:50 pmRNSAGM Statement
24th Aug 20214:50 pmRNSRESULTS OF ANNUAL GENERAL MEETING
23rd Aug 20217:30 amRNSProsus Share Repurchase Programme
23rd Aug 20217:30 amRNSShare Repurchase Programme
20th Aug 20214:45 pmRNSDirector/PDMR Shareholding
20th Aug 20214:45 pmRNSDirector/PDMR Shareholding
16th Aug 20217:00 amRNSSettlement Exchange Offer – AFM Notifications
16th Aug 20217:00 amRNSCapital Restructure and Exchange Offer Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.